Skip to main content
NewslettersWatchlist

Latest

featured reports
Cannabis ETFs have crumbled since legalization – is now the time to buy in?
report on business
Aphria sales fail to impress Street as COVID-19 pinches drug distribution
inside the market
Market movers: Stocks that saw action on Wednesday - and why
report on business
Cannabis-producer Aphria shares plunge on larger-than-expected loss
report on business
Aphria issues shares to Emblem after reaching settlement in supply dispute
report on business
Aphria signs $29-million deal to settle dispute with Aleafia and Emblem
advisor stocks
Is cannabis still a long-term play worth considering?
report on business
Aphria suspends outlook, reports $144.4-million in revenue amid COVID-19
inside the market
What every Canadian investor needs to know today
report on business
Aphria investment raises $100-million from unnamed institutional investor
cannabis
Aphria signs $100-million deal with unidentified institutional investor
report on business
Aphria cuts outlook for 2020, reports second-quarter loss
cannabis
Aphria cuts 2020 outlook as cannabis company faces setbacks in Ontario, Alberta
inside the market
Pot-stock interest fizzled in 2019. These charts show how much
board games 2019
How we ranked Canada’s corporate boards
cannabis
Canadian regulators warn cannabis companies to improve conflict-of-interest disclosures
cannabis
All dried up: How Bay Street cashed in on the cannabis frenzy before the carnage
report on business
Aphria gives new CEO $10-million pay package
report on business cannabis professional
Aleafia cancels supply agreement with Aphria, cites ‘consistent failure’ to meet obligations
number cruncher
Four cannabis stocks for the longer-term investor as the market hype cools
Prev
123
Next

21 - 40 of 135 articles